It gives us immense pleasure to invite you all to the “International Congress on Frontiers in Urologic Oncology and Uropathology” - an international conference that will take place in the temple city of the Bhubaneswar, Odisha, India, from 10th to 12th January, 2025, jointly organized by the Genitourinary Pathology Society, Kalinga Institute of Medical sciences, All India Institute of Medical Sciences- Bhubaneswar, Odisha Society of Oncology, Temple city Oncomeet, Medical Education Unit, and International Association for Integrated Oncology, with the mission to foster a global community of Urologic Oncology and Uropathology researchers and professionals, providing a platform for intellectual growth, and creating opportunities for networking and collaboration. Indeed, this would be the first such event that will bring together world-renowned Uro-oncologists and pathologists, who work in the field of genitourinary oncology onto a common platform. The academic event will be beneficial for the budding as well as practicing pathologists and uro-oncologists. It will also provide opportunity to physicians for meeting and networking with the stalwarts in the field of urologic oncology. The topics covered over the three days are designed to cater to the needs of all those who are interested in urologic pathology and urologic oncology. A panel of fifteen international faculties who are the experts in their fields will grace the event which makes it a coveted one to learn about the entire realm of urologic pathology and oncology. In addition, there will be a presentation and quiz for the budding physicians Dear Friends Greetings from the Land of Lord Jagannath! (trainees in Oncology, and Pathology) which make it a much sought after event.
Register on or before 31st October 2024 to avail Early Bird Registration Fees Register Now !!
Submit your abstracts on or before 25th December 2024 Submit Now !!
Meet our International Speakers for the Conference View Now
Scientific Agenda has been Released View the Agenda
Know More about the Venue
Need Any assistance for the conference Contact Us
31st October 2024
01st November 2024
25th December 2024
AIIMS Bhubaneswar
Nadiad
USC Keck School of Medicine
UT Southwestern University
Tea, coffee, water along with refreshments will be served throughout the sessions and across the day in the auditorium
Chairpersons : Dr. Urmila Senapati, Dr. Nandita Kakkar, Dr. Samir K. Behera , Dr. Kaumudee Pattnaik, Dr. Sudipta Mohakud, Dr. Lity Mohanty
Multiparametric MRI in Prostate Cancer Diagnosis and Management: Role of Pathologist – Dr. Cristina Magi-Galluzzi (8:30 AM - 9:05 AM)
Contemporary Update on Prostate Cancer Grading – Dr. Ming Zhou (9:05 AM - 9:40 AM)
Chairpersons: Dr. Rabinarayan Mallick, Dr. Sangeeta Desai, Dr. Nuzhat Husain, Dr. Lity Mohanty, Dr. Niharika Panda, Dr. Matthew O. Leavitt
Applications of Digital and Computational Pathology and Artificial Intelligence in Genitourinary Pathology Diagnostics – Dr. Mahul B. Amin
Chairpersons : Dr. T. S. Ganesan, Dr. Debahuti Mohapatra, Dr. Dipti Rani Samanta, Dr. Saroj K. Das Majumdar, Dr. Aiman Haider
Prostate Surgery without histopathology proof in era of modern and molecular imaging - Dr. Makarand Khochikar (10:15 AM - 10:35 AM)
Debate: PSMA PET - CT is the imaging of choice in Prostate Cancer (10:35 AM - 10:50 AM)
For: Dr. Girish K. Parida
Against: Dr. Biswajit Sahoo
Expert comment: Dr. Makarand Kochikar
Localized prostate cancer - multimodality management
Chairpersons : Dr. Anita Ramesh, Dr. Amit Joshi, Dr. Anuradha Sekaran, Dr. Subhashis Mohanty, Dr. Ghanashyam Biswas, Dr. Soumya S. Panda
Moderator : Dr. Surendra N. Senapati
Panelist :
Chairpersons : Dr. Surendra N. Senapati, Dr. Anita Ramesh, Dr. Amit Joshi, Dr. Anuradha Sekaran, Dr. Ghanashyam Biswas, Dr. Soumya S. Panda, Dr. Makarand Khochikar, Dr. Subhashis Mohanty
Oligometastatic prostate cancer: Current understanding and consensus on multi - modality management - Dr. Sandy Srinivas
Metastatic hormone sensitive prostate cancer : Choosing wisely -Dr. Krishna Kumar Rathnam (12:05 PM - 12:25 PM)
Chairpersons : Dr. Mahul B. Amin, Dr. Rajal B Shah, Dr. Sambit K. Mohanty, Dr. Sourav K. Mishra, Dr. Ranjana Giri
Guardant NGS in GU malignancies - Dr. Soumya S. Panda (12:25 PM - 12:55 PM) by Zydus Lifesciences
Improving outcomes in prostate cancer care with AI - based risk stratification - Dr. Uttara Joshi (12:55 PM - 1:25 PM) by AIRA Matrix
Castrate resistant prostate cancer - by Intas Pharmaceuticals
Chairpersons : Dr. Krushna. B. Das, Dr. Kshitish C. Mishra , Dr. Santosh Menon, Dr. Asaranti Kar, Dr. Sunil Agarwala
Moderator : Dr. Anita Ramesh
Panelist
Chairpersons:Dr. Krushna. B. Das, Dr. Kshitish C. Mishra , Dr. Santosh Menon, Dr. Asaranti Kar, Dr. Sunil Agarwala
Divergent Differentiations and Variant Histologies of Bladder Cancer – Dr. Gladell P. Paner (2:35 PM - 3:10 PM)
Germ Cell Tumors of the Testis: Diagnoses that You Do Not Want to Miss – Dr. Andres M. Acosta (3:10 PM – 3:45 PM)
Chairpersons : Dr. Ghanashyam Biswas, Dr. Santosh Menon, Dr. Manas R. Pradhan, Dr. Tanushree Mishra, Dr. Rajan Arora, Dr. Pritinanda Mishra
Penile Cancer: A pathologist's perspective on current trends in diagnosis, staging, and treatment – Dr. Jasreman Dhillon (3:45 PM -4:20 PM)
Chairpersons : Dr. Padmalaya Nayak, Dr. Sandhya Sundaram, Dr. Sonia Badwal, Dr. Rajni Parmar, Dr. Anuradha Sekeran, Dr. Kalpalata Tripathy, Dr. Paromita Roy
Treatment-related neuroendocrine carcinoma of the prostate - Dr. Rajal B. Shah (4:20 PM - 4:35 PM)
Molecularly defined renal cell carcinomas - Dr. Rohit Mehra (4:35 PM - 4:50 PM)
Ductal adenocarcinoma of the prostate - Dr. Ming Zhou (4:50 PM - 5:05 PM)
Endophytic tumors of the urinary tract - Dr. Gladell P. Paner (5:05 PM - 5:15 PM)
Non-epithelial tumors of the penis - Dr. Jasreman Dhillon (5:15 PM - 5:35 PM)
Chairpersons : Dr. Samarendra Dash, Dr. Sanjay Mishra, Dr. Goutam Panda, Dr. Rajan Arora
Oral GnRH analogues: Recent updates - Dr. Susant K. Paikaray (5:35 PM - 5:55 PM) by Zydus Lifesciences
Evolving landscape in hormonal management of prostate cancer - Dr. Amit Joshi (5:55 PM - 6:15 PM) by AstraZeneca
Cultural program (6:15 PM - 7:00 PM)
Faculty Dinner (7:00 PM Onwards)
Judges: Dr. Nandita Kakkar, Dr. Sandhya Sundaram, Dr. Nuzhat Husain, Dr. Seema Kaushal, Dr. Rajni Parmer, Dr. Santosh Menon, Dr. Sonal Sharma, Dr. Pritinanda Mishra
Pathology : Oral Presentations (10:30 AM - 1:00 PM)
Judges : Dr. Amit Sehrawat, Dr. Sharada Mailankody, Dr. Abhishek Raj, Dr. Sthiti Das, Dr. Sunil Jaiswal
Clinical : E - Poster Presentations (2:30 PM - 3:45 PM)
Tea, coffee, water along with refreshments will be served throughout the sessions and across the day in the auditorium.
Chairperson: Dr. Makarand Khochikar, Dr. Padmalaya Devi, Dr. Amitabh Jena, Dr. Sunil Jaiswal, Dr. Soumya S. Panda, Dr. Sulata Choudhury
Augmenting Prostate Cancer Diagnosis with AI: Real-World Insights, Challenges & Solutions -Ms. Shriya Kumar (8:00 AM - 8:25 AM) by Qritive
Role of HPV in the management of penile cancer: Where do we stand ? - Dr. Philip E. Spiess
Chairpersons : Dr. Prafulla K. Das, Dr. Lalatendu Sarangi, Dr. Susama Patra, Dr. Seema Kaushal, Dr. Manas R. Baishakh, Dr. Sonal Sharma, Dr. Meenakshi Swain
Large Gland Lesions of the Prostate - Dr. Rajal B. Shah (9:05 AM – 9:40 AM)
How New Developments Impact Diagnosis in Existing Renal Neoplasms – Dr. Sean R. Willamson (9:40 AM - 10:15 AM)
Pink Cell Tumors of the Kidney: Making Sense – Dr. Rohit Mehra (10:15 AM – 10:50 AM)
Chairpersons : Dr. Sandhya Sundaram, Dr. Seema Kaushal, Dr. Dilleswari Pradhan, Dr. Sagarika Samantaray, Dr. Poonam Elhence, Dr. Ruchi Mittal, Dr. Dilip K. Kar , Dr. Soumya S. Panda, Dr. Srigopal Mohanty, Dr. Meenakshi Swain
Clear cell and papillary tumors of the kidney - Dr. Sean R. Williamson (10:50 AM - 11:05 AM)
Sex cord-stromal tumors of the testis - Dr. Andres M. Acosta (11:05 AM - 11:20 AM)
An interesting Kidney tumor - Dr. Jayaram N. Iyengar (11:20 AM - 11:30 AM)
Chairpersons : Dr. Chira Ranjan Khadanga, Dr. Surendra N. Senapati, Dr. Sanjib Mishra, Dr. Susant K. Paikaray, Dr. Debahuti Mohapatra, Dr. Alaka Sahu, Dr. Seema Kaushal, Dr. Pranita Sahu, Dr. Pranati Pradhan, Dr. Sunayana Misra, Dr. Pallavi Bhuyan
Optimum Management of Urothelial Carcinoma and Role of Tecentriq - Dr. Chinmaya K. Pani (11:30 AM – 12:00 PM) by Roche
The Key Role Urology is Playing in Defining Pathology's Digital Future - Dr. Matthew O. Leavitt (12:00 PM - 12:25 PM) by Lumea
Chairpersons : Dr. Surendra N. Senapati, Dr. Swodeep Mohanty, Dr. Kunal Goutam, Dr. Ranajit Kar, Dr. Manas R. Baisakh, Dr. Subhashis Mohanty
Non-muscle invasive bladder cancer: Management principles and recent advances - Dr. Makarand Kochikar (12:55 PM - 1:10 PM)
Debate : Bladder Preservation Strategies in Bladder Cancer - Combined modality treatment is preferred over Radical cystectomy in locally advanced bladder cancer (1:10 PM - 1:25 PM)
For: Dr. Suman Das
Against: Dr. Sunil Agarwala
Expert Comment - Dr. Siddhartha Nanda
Paradigm shift in management of muscle invasive bladder cancer -
Dr. Atul Batra (1:25 AM – 1:50 PM) by Astrazeneca
Neoadjuvant and adjuvant strategies in bladder cancer.
Chairpersons : Dr. Murali Varma, Dr. Deepak Rautray, Dr. Makarand Khochikar, Dr. Amit Joshi
Moderator : Dr. Dipti Rani Samanta
Panelist
Optimising treatment strategies in metastatic urothelial cancer - Dr. Srigopal Mohanty (2:30 PM - 2:50 PM) by Merck
Role of Opdyta in Adjuvant Urothelial carcinoma - Dr. Srigopal Mohanty (2:50 PM - 3:10 PM) by Bristol Myers Squibb (BMS)
Chairpersons : Dr. Murali Varma, Dr. Makarand Khochikar, Dr. Mahul B. Amin, Dr. Deepak Rautray, Dr. Amit Joshi, Dr. Nachiketa Mohaptra, Dr. Siddhartha Nanda, Dr. Rohit Mehra
Metastatic Urothelial Carcinoma: New Horizons with emphasis on Antibody Drug Conjugates : Dr. Ajjai S. Alva (3:10 PM - 3:45 PM)
Clinical management of variant histologies of bladder cancer - Dr. Bivas Biswas (3:45 PM - 4:00 PM)
Improving Survival and Quality of Life in frontline advanced RCC with CTLA-4 & PD - 1 inhibition -by Bristol Myers Squibb (BMS)
Moderator : Dr. Bivas Biswas
Panelist
Chairpersons : Dr. Susama Patra, Dr. Rajan Arora, Dr. Mohini Rao, Dr. Indranil Chakrabarti
Troubleshooting and QC in IHC - Mr. Kamal Peddinti (4:40 PM - 5:00 PM) by PathnSitu Biotechnologies
Role of Denosumab in Prostrate Cancer - Preventive & Therapeutic Approach - Dr. Srigopal Mohanty (5:00 PM - 5:15 PM) by Reliance Life Sciences
Liquid Biopsy in Cancer Care: Real-World Applications and Understanding - Dr. Safi Gowhar (5:15 PM - 5:35 PM) by OneCell Diagnostics
Inauguration & Cultural program (6:00 PM - 7:30 PM)
Banquet Dinner (7:30 PM Onwards)
Judges: Dr. T .S. Ganesan, Dr. Krishna K. Rathnam, Dr. Siddharth Nanda, Dr. Soumya S. Panda, Dr. Surendra N. Senapati, Dr. Sunil Agarwala
PClinical : Oral Presentations (9:30 AM - 11:30 AM)
Judges : Dr. Rajiv Tangri, Dr. Bijal Kulkarni, Dr. Sankalp Sancheti, Dr. Rupanita Biswal, Dr. Shilpy Jha, Dr. Rashmi Patnaik, Dr. Preeti Diwaker, Dr. Rohan Sardana, Dr. Vikram Mathew, Dr. Shivani Gandhi, Dr Reetika Menia, Dr. Pavithra A, Dr. Poonam Elhence, Dr. Shruti Sabnis, Dr. Aimen Haider, Dr. Rajan Arora
Pathology : E - Poster Presentations (1:00 PM - 3:00 PM)
Tea, coffee, water along with refreshments will be served throughout the sessions and across the day in the auditorium.
Chairperson : Dr. Mahul B. Amin, Dr. Rajal B. Shah, Dr. Sambit K. Mohanty, Dr. Sourav K. Mishral
The Dynamic Duo : CTC and ctDNA - Dr. Jayant Khandare (8:00 AM - 8:25 AM) by OneCell Diagnostics
Chairperson : Dr. Bidhu Mohanti, Dr. Sean R. Williamson, Dr. Birendranath Banerjee
Debate RCC : Adjuvant immunotherapy is the current standard of care in RCC – (8:30 AM - 8:45 AM)
For: Dr. Aditya Sarin
Against: Dr. Srigopal Mohanty
Expert Comment - Dr. Rejiv Rajendranath
Combining systemic therapy with local therapy (SBRT) in mRCC : Dr. Lucy Pattanayak (8:45 AM - 9:05 AM)
Metastatic renal cell cancer second line and beyond
Chairperson : Dr. Krupasindhu Panda, Dr. Lalatendu Sarangi, Dr. T. S. Ganesan, Dr. Ravindra B. Sabnis, Dr. Mohini Rao
Moderator : Dr. Atul Sharma
Panelist :
Chairperson : Dr. Bidhu Mohanti, Dr. Atul Sharma, Dr. Saroj K. Das Majumdar, Dr. Dipti Rani Samanta, Dr. Sanjukta Padhi, Dr. Manas R. Pradhan, Dr. Nachiketa Mohapatra
Communicating Pathology Results for Personalized Medicine: How Are the Surgical Members of the Society of Urologic Oncology Using Pathology Reports to Guide the Treatment of Prostate Cancer Patients? - Dr. Murali Varma
Genitourinary malignancies: Making sense of Indian data from low - and middle - income countries with emphasis on conducting collaborative research - Dr. Atul Batra - (10:15 AM - 10:30 AM)
Germ cell tumor
Moderator : Dr. Rejiv Rajendranath
Panelist
Beyond immunotherapy and TKI in Management of Renal Cell Carcinoma - Dr. Aditya Sarin (11:10 AM - 11:25 AM)
Chairperson : Dr. Sushil Giri, Dr. Jita Parija, Dr. Sweta Singh
Recent advances in advanced Endometrial Cancer by AstraZeneca
Moderator : Dr. Ghanashyam Biswas
Panelist
Neuroendocrine carcinoma in urogenital tract: Multimodality management in case-based discussions
Chairperson : Dr. Prafulla K. Das, Dr. Sabyasachi Parida, Dr. Indranil Chakrabarti
Moderator : Dr. Sandy Srinivas
Panelist
Pathologic sub-staging of bladder cancer – updates, controversies, and guidelines - Dr. Ankur Sangoi (12:45 PM - 1:15 PM)
Benign mimics of urothelial carcinoma - Dr. Ankur Sangoi (1:15 PM - 1:30 PM)
Best practice recommendation for immunohistochemical markers in renal cell tumors - Dr. Mahmut Akgul (1:30 PM – 2:00 PM)
Mesenchymal lesions of the GU tract - Dr. Mahmut Akgul (2:00 PM – 2:15 PM)
Lunch break (2:15 PM - 2:45 PM)
Valedictory (2:45 PM - 3:15 PM)
Discover groundbreaking insights and forge connections with eminent speakers and industrialist at our conference, where innovation meets expertise for a transformative experience.
Kalinga Institute of Medical Sciences, Bhubaneshwar, Odisha, India
gupsindiaconclave@iaoncology.org
+91-8925642775
+12027548501 (USA, Canada and Others)
